Clinical trial
APIDRA Registration Study
NCT00489190 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00489190 |
|---|---|
| Title | APIDRA Registration Study |
| Official title | Local, Open, Non-Randomized, Phase IV Clinical Study for the Collection of Data Regarding the Drug Portability Received During the Treatment With Subcutaneous Injection of Apidra Glulisine (HMR1964) to Patients With Diabetes Mellitus 1st Type |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | Insulin Glulisine |
| Enrollment | 45 |
| Start date | Aug 1, 2005 |
| First posted | Jun 21, 2007 |
| Last update posted | Mar 16, 2009 |
| Countries | Kazakhstan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: